InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Robb Rhonda J., Chief Executive Officer. Insider active across 1 companies, notably Cardiovascular Systems Inc. In total, 12 disclosures have been published. Total volume traded: €108k. The latest transaction was disclosed on 7 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
€25,6011,567 shares@ €16.337612.6% of flow
Common Stock
SEC:0001437749-22-002890·
Ideal exit: 4 Nov 2022 (T+270)
€25,6011,567 shares@ €16.33766.3% of flow
Common Stock
SEC:0001437749-22-002890:0·
Ideal exit: 4 Nov 2022 (T+270)
€47,8201,589 shares@ €30.094223.5% of flow
Common Stock
SEC:0000914190-21-000315·
€47,8201,589 shares@ €30.094211.7% of flow
Common Stock
SEC:0000914190-21-000315:0·
09,630 shares0
Common Stock
SEC:0000914190-21-000297·
09,630 shares0
Common Stock
SEC:0000914190-21-000297:0·
€101,9133,316 shares@ €30.733850.0% of flow
Common Stock
SEC:0000914190-21-000271·
€101,9133,316 shares@ €30.733825.0% of flow
Common Stock
SEC:0000914190-21-000271:0·
010,147 shares0
Common Stock
SEC:0000914190-21-000237·
010,147 shares0
Common Stock
SEC:0000914190-21-000237:0·
€28,5561,000 shares@ €28.55614.0% of flow
Common Stock
SEC:0000914190-21-000142·
Ideal exit: 4 Feb 2022 (T+270)
€28,5561,000 shares@ €28.5567.0% of flow
Common Stock
SEC:0000914190-21-000142:0·
Ideal exit: 4 Feb 2022 (T+270)
12 of 12 declarations
About Robb Rhonda J.
Rhonda J. Robb is the Chief Operating Officer at Cardiovascular Systems Inc, a company specializing in medical devices. She oversees the company's operations and is responsible for optimizing operational processes.
